Montgomery & Co. initiates Endocare coverage

Montgomery & Co., LLC analyst Wade H. King began coverage of Endocare, Inc., a medical device company which develops, manufactures and markets minimally invasive cryoablation products for the treatment of cancerous tumors. Shares of the Irvine, Calif., medical device company were up 10 cents, or 3.70%, at $2.80 on volume of 93,515 shares. (OTCBB: ENDO)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.